Nombre | Último | Anterior | Máximo | Mínimo | % Var. | Vol. | Hora | Precio | |
---|---|---|---|---|---|---|---|---|---|
MBPH Moberg Pharma AB | 11,23 | 28,86 | 14,56 | 9,73 | -61,09% | 12,89M | 11,23-61,09% | 13/09 | |
XBRANE Xbrane Biopharma AB | 0,14 | 0,15 | 0,16 | 0,14 | -6,67% | 6,6M | 0,14-6,67% | 13/09 | |
VICOR Vicore Pharma Holding AB | 7,16 | 7,28 | 7,59 | 7,14 | -1,65% | 2,01M | 7,16-1,65% | 13/09 | |
ATORX Alligator Bioscience AB | 1,326 | 1,284 | 1,34 | 1,264 | +3,12% | 1,81M | 1,326+3,12% | 13/09 | |
ONCO Oncopeptides AB | 2,195 | 2,305 | 2,34 | 2,15 | -4,77% | 1,73M | 2,195-4,77% | 13/09 |
Nombre | Precio |
---|---|
MEDIVIR Medivir B | 3,50+0,59+20,27% |
SYNACT SynAct Pharma AB | 8,81+0,44+5,26% |
ISOFOL Isofol Medical | 2,695+0,1250+5,06% |
SANION Saniona AB | 4,71+0,20+4,43% |
ATORX Alligator Bioscience | 1,326+0,0420+3,12% |
Nombre | Precio |
---|---|
MBPH Moberg Pharma | 11,23-17,63-61,09% |
XBRANE Xbrane Biopharma | 0,14-0,01-6,67% |
ABLI Abliva AB | 0,18-0,01-5,26% |
IBTb Infant Bacterial Therapeutics | 35,00-1,80-4,89% |
ONCO Oncopeptides | 2,195-0,110-4,77% |